There are so many uncertainties that it remains unwise to get carried away by the potential economic boost from the latest wave of weight loss drugs. Nonetheless, if use of the drugs continues to grow rapidly, it could ultimately give a significant boost to GDP by boosting labour market activity. Even if this isn’t the case, the bigger picture is that we could be on the brink of a new wave of AI-aided healthcare innovation.
In view of the wider interest, we are also sending this Long Run Update to clients of our Global Economics service.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services